BUONFIGLIOLI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 3.020
AS - Asia 2.828
EU - Europa 1.593
AF - Africa 161
SA - Sud America 115
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.723
Nazione #
US - Stati Uniti d'America 2.980
VN - Vietnam 1.173
SG - Singapore 709
CN - Cina 485
GB - Regno Unito 434
SE - Svezia 227
DE - Germania 197
IT - Italia 192
HK - Hong Kong 141
FR - Francia 109
IN - India 103
RU - Federazione Russa 96
BR - Brasile 82
IE - Irlanda 75
CI - Costa d'Avorio 61
NL - Olanda 60
ZA - Sudafrica 46
UA - Ucraina 45
BD - Bangladesh 44
EE - Estonia 39
KR - Corea 39
JP - Giappone 35
TG - Togo 30
CA - Canada 29
BG - Bulgaria 24
FI - Finlandia 21
PH - Filippine 21
CH - Svizzera 18
JO - Giordania 15
PL - Polonia 13
EC - Ecuador 10
TH - Thailandia 10
BE - Belgio 9
GR - Grecia 9
TR - Turchia 9
AR - Argentina 8
ES - Italia 8
MX - Messico 8
TW - Taiwan 8
IQ - Iraq 7
NG - Nigeria 7
AT - Austria 6
PK - Pakistan 6
SA - Arabia Saudita 6
AU - Australia 5
IR - Iran 5
SC - Seychelles 5
PE - Perù 4
CL - Cile 3
MA - Marocco 3
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
ID - Indonesia 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
PY - Paraguay 2
SI - Slovenia 2
UY - Uruguay 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GN - Guinea 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
MT - Malta 1
NP - Nepal 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
TN - Tunisia 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
Totale 7.723
Città #
Singapore 532
Southend 379
Ashburn 368
Fairfield 330
Ho Chi Minh City 279
Hanoi 260
Chandler 232
Woodbridge 146
San Jose 138
Hong Kong 132
Houston 126
Seattle 123
Wilmington 116
Santa Clara 107
Ann Arbor 101
Dong Ket 96
Boardman 84
Cambridge 83
Princeton 78
Dublin 75
Beijing 65
Abidjan 61
Dallas 49
Da Nang 47
Los Angeles 45
Hefei 44
Bologna 41
Westminster 40
New York 39
Haiphong 35
Lauterbourg 33
Tokyo 33
Nanjing 32
São Paulo 31
Lomé 30
Medford 27
Council Bluffs 26
Bremen 25
Saint Petersburg 25
Buffalo 24
Milan 24
Sofia 24
Dearborn 23
Padova 23
Seoul 23
Florence 21
Ha Long 21
Biên Hòa 19
Hải Dương 19
Thái Nguyên 19
Berlin 17
Munich 17
Can Tho 16
Falls Church 16
Quận Bình Thạnh 16
Amman 15
Changsha 14
Frankfurt am Main 14
San Diego 14
Helsinki 13
Toronto 13
Bắc Ninh 12
Guangzhou 12
Jacksonville 12
Jinan 12
Redondo Beach 12
Shenyang 12
Bern 11
London 11
Pune 11
Turin 11
Xi'an 11
Bắc Giang 10
Brussels 9
Des Moines 9
Hebei 9
Ninh Bình 9
Shanghai 9
Tianjin 9
Zhengzhou 9
Jiaxing 8
Orem 8
Quận Phú Nhuận 8
Turku 8
Falkenstein 7
Johannesburg 7
Montreal 7
Nanchang 7
Vinh 7
Vũng Tàu 7
Abeokuta 6
Bangkok 6
Chicago 6
Guayaquil 6
Quảng Ngãi 6
Quận Ba 6
Tây Ninh 6
Uyen Hung 6
Warsaw 6
Yubileyny 6
Totale 5.252
Nome #
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 614
Outcomes and survival after TIPS positioning: a single center experience 407
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 255
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 237
Adverse effects of proton pump inhibitors. 219
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 217
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 216
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 212
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 205
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 204
Alisporivir for the treatment of chronic HCV 202
Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD) 199
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 199
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 194
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 189
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 184
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 182
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 179
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 179
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 174
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 170
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 163
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 162
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 159
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 159
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 158
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 157
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 156
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 155
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 155
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 150
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 143
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 138
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 136
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 135
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 133
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 130
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 123
Outcomes and survival after TIPS positioning: a single center experience 120
null 107
null 96
Lamivudine treatment for severe acute HBV hepatitis. 71
null 65
THE GASTROPACK SYSTEM, A NOVEL METHOD TO ACCESS TO GASTROENTEROLOGICAL CARE: RESULTS OF THE UPPER GASTROINTESTINAL SYMPTOM POPULATION 34
Totale 7.842
Categoria #
all - tutte 19.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 0 0 132
2021/2022886 94 24 36 54 69 43 12 47 24 39 303 141
2022/2023859 84 119 50 128 56 83 21 42 152 18 64 42
2023/2024265 9 46 8 22 14 89 10 16 25 5 11 10
2024/2025936 52 141 96 50 133 35 41 25 26 71 45 221
2025/20263.001 816 161 184 136 265 129 260 78 554 204 75 139
Totale 7.842